Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xencor (XNCR) Cash & Equivalents (2016 - 2025)

Xencor (XNCR) has disclosed Cash & Equivalents for 13 consecutive years, with $54.1 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 32.29% to $54.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $54.1 million through Dec 2025, up 32.29% year-over-year, with the annual reading at $54.1 million for FY2025, 32.29% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $54.1 million at Xencor, up from $28.3 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $177.0 million in Q1 2021, with the low at $28.3 million in Q3 2025.
  • Average Cash & Equivalents over 5 years is $61.2 million, with a median of $51.0 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents surged 139.76% in 2021, then plummeted 62.4% in 2022.
  • Over 5 years, Cash & Equivalents stood at $143.5 million in 2021, then tumbled by 62.4% to $53.9 million in 2022, then decreased by 0.28% to $53.8 million in 2023, then fell by 24.01% to $40.9 million in 2024, then surged by 32.29% to $54.1 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $54.1 million, $28.3 million, and $44.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.